HU0005010D0 - - Google Patents

Info

Publication number
HU0005010D0
HU0005010D0 HU0005010A HUP0005010A HU0005010D0 HU 0005010 D0 HU0005010 D0 HU 0005010D0 HU 0005010 A HU0005010 A HU 0005010A HU P0005010 A HUP0005010 A HU P0005010A HU 0005010 D0 HU0005010 D0 HU 0005010D0
Authority
HU
Hungary
Prior art keywords
relates
vaccines
bacteria
vaccine
prevention
Prior art date
Application number
HU0005010A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of HU0005010D0 publication Critical patent/HU0005010D0/hu
Publication of HUP0005010A2 publication Critical patent/HUP0005010A2/hu
Publication of HUP0005010A3 publication Critical patent/HUP0005010A3/hu
Publication of HU226192B1 publication Critical patent/HU226192B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HU0005010A 1999-12-28 2000-12-27 Salmonella vaccine HU226192B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99204564 1999-12-28

Publications (4)

Publication Number Publication Date
HU0005010D0 true HU0005010D0 (enExample) 2001-02-28
HUP0005010A2 HUP0005010A2 (en) 2002-06-29
HUP0005010A3 HUP0005010A3 (en) 2004-07-28
HU226192B1 HU226192B1 (en) 2008-06-30

Family

ID=8241112

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0005010A HU226192B1 (en) 1999-12-28 2000-12-27 Salmonella vaccine

Country Status (15)

Country Link
US (2) US20010021386A1 (enExample)
EP (1) EP1112747B1 (enExample)
JP (1) JP5745731B2 (enExample)
AT (1) ATE269104T1 (enExample)
AU (1) AU783508B2 (enExample)
BR (1) BR0006291B1 (enExample)
CA (1) CA2329676A1 (enExample)
DE (1) DE60011560T2 (enExample)
DK (1) DK1112747T3 (enExample)
ES (1) ES2222152T3 (enExample)
HU (1) HU226192B1 (enExample)
MX (1) MXPA00012796A (enExample)
PL (1) PL206377B1 (enExample)
PT (1) PT1112747E (enExample)
TR (1) TR200401569T4 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4751570B2 (ja) * 2002-09-11 2011-08-17 東レ・ダウコーニング株式会社 オルガノポリシロキサン変性多糖類およびその製造方法
EP2517723B1 (en) 2006-09-18 2019-11-06 The Board of Trustees of The University of Arkansas Compositions and methods of enhancing immune responses
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
BRPI0818736A2 (pt) * 2007-10-30 2017-06-13 Univ Arkansas composições e métodos para intensificar imunorrepostas à bactéria flagelada
WO2009059298A2 (en) 2007-11-01 2009-05-07 Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancinc immune responses to eimeria
CA2703519C (en) 2007-11-09 2017-04-18 The Salk Institute For Biological Studies Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors
CN102811734B (zh) 2010-01-21 2016-02-10 阿肯色大学评议会 增强免疫应答的疫苗载体和方法
CA2800830C (en) 2010-06-09 2020-09-08 The Board Of Trustees Of The University Of Arkansas Vaccine and methods to reduce campylobacter infection
KR101449417B1 (ko) 2012-06-20 2014-10-27 한국외국어대학교 연구산학협력단 살모넬라 엔테리카의 박테리오파아지 및 그 용도
WO2014097154A1 (en) 2012-12-20 2014-06-26 Zakład Badawczo-Wdrożeniowy Ośrodka Salmonella "Immunolab" Sp. Z O.O. A polyvalent combined immunising and/or therapeutic preparation for use in bacterial infections or food poisoning, particularly salmonellosis, a method for production of this preparation, its use and a vaccine comprising this preparation
HUE047484T2 (hu) 2013-02-14 2020-04-28 Univ Arkansas Készítmények és eljárások eimeria elleni immunválasz fokozására vagy eimeria-fertõzés korlátozására
US9845341B2 (en) 2013-03-11 2017-12-19 The Brigham And Women's Hospital, Inc. Vibro-based delivery system and immune suppression
US10376571B2 (en) 2013-03-15 2019-08-13 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to enteric pathogens
KR20190015712A (ko) 2016-05-03 2019-02-14 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 면역자극 및 항원 폴리펩티드를 포함하는 효모 백신 벡터, 및 그를 이용하는 방법
CN111374094B (zh) * 2020-03-02 2022-04-19 扬州大学 驴源马流产沙门氏菌经皮下致非妊娠期小鼠子宫感染模型的建立方法
CN118773056B (zh) * 2024-07-10 2025-07-08 山东省滨州畜牧兽医研究院 一种马流产沙门氏菌灭活疫苗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1109179A (en) * 1964-09-30 1968-04-10 Nat Res Dev Improvements relating to typhoid and paratyphoid vaccines
ES2060580T3 (es) * 1986-03-11 1994-12-01 Shionogi & Co Adn que tiene una secuencia adn codificante de la proteina flagelina y vector que la contiene.
US6130082A (en) * 1988-05-05 2000-10-10 American Cyanamid Company Recombinant flagellin vaccines
DE68922394T2 (de) * 1988-05-05 1995-10-05 Praxis Biolog Inc Rekombinante vakzine von flagellin.
AU640118B2 (en) * 1988-12-19 1993-08-19 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur Meningococcal class 1 outer-membrane protein vaccine
DK0744937T3 (da) * 1994-02-18 2002-10-28 Solidose L L C Vaccination af dyr med tørrede, pelleterede biologiske materialer
GB9621091D0 (en) * 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
US6190669B1 (en) * 1998-05-13 2001-02-20 University Of Maryland, Baltimore Attenuated mutants of salmonella which constitutively express the Vi antigen

Also Published As

Publication number Publication date
EP1112747A1 (en) 2001-07-04
BR0006291A (pt) 2001-11-27
PL206377B1 (pl) 2010-08-31
JP5745731B2 (ja) 2015-07-08
ATE269104T1 (de) 2004-07-15
HUP0005010A2 (en) 2002-06-29
PT1112747E (pt) 2004-10-29
ES2222152T3 (es) 2005-02-01
MXPA00012796A (es) 2002-05-23
US20080069843A1 (en) 2008-03-20
JP2001186874A (ja) 2001-07-10
HU226192B1 (en) 2008-06-30
DE60011560D1 (de) 2004-07-22
EP1112747B1 (en) 2004-06-16
CA2329676A1 (en) 2001-06-28
AU783508B2 (en) 2005-11-03
BR0006291B1 (pt) 2014-02-18
PL344851A1 (en) 2001-07-02
DK1112747T3 (da) 2004-10-25
US20010021386A1 (en) 2001-09-13
AU7245300A (en) 2001-07-05
DE60011560T2 (de) 2005-08-18
TR200401569T4 (tr) 2004-07-21
HUP0005010A3 (en) 2004-07-28

Similar Documents

Publication Publication Date Title
PL344851A1 (en) Bacterium of salmonella type and vaccine containing that bacterium for protecting animals against salmonellosis and method of obtaining such vaccine
WO2004060308A3 (en) Thiosemicarbazones as anti-virals and immunopotentiators
MXPA03008961A (es) Composicion de vacuna.
WO2002009643A3 (en) Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
WO2006076285A3 (en) Adhesin as immunogen against escherichia coli
WO2002087494A3 (en) Novel vaccine
EP1264603B8 (en) Use of L-polynucleotides for in vivo imaging
EP1572918A4 (en) SYNTHETIC GLYCOLIPOPEPTIDES AS VACCINES
WO2002045742A8 (en) Lipoteichoic acid immunogenic compositions and methods of making and using thereof
GB0121998D0 (en) Attenuated bacteria useful in vaccines
EP1532131A4 (en) COMPOUNDS OF THE MOTILID TYPE
MXPA02012857A (es) Uso de una formulacion elaborada de o que contiene al menos un suero de leche dismilado.
WO2003060088A3 (en) Viral vaccine production method
SG147465A1 (en) Vaccine
HU9801705D0 (en) Streptococcus equi vaccine
ZA200002615B (en) Live attenuated bacteria for use in a vaccine.
NZ295877A (en) A vaccine comprising the helicobacter bacterium and its use
WO2005021031A3 (en) Live attenuated bacterial vaccine
AU6761301A (en) Adjuvant composition comprising fha protein or fragment of fha protein in free form
RU2002122063A (ru) Штам бактерий leptospira interrogans "митронов" серогруппы canicola для приготовления вакцины
GB9919732D0 (en) Trehalose producing cells as vaccines
RU99117151A (ru) Штамм бактерий pseudomonas aeruginosa 5002, используемый для изготовления вакцины против псевдомоноза пушных зверей
RU99117153A (ru) Штамм бактерий pseudomonas aeruginosa 4762, используемый для изготовления вакцины против псевдомоноза пушных зверей
RU99117152A (ru) Штамм бактерий pseudomonas aeruginosa 4492, используемый для изготовления вакцины против псевдомоноза пушных зверей
RU99117155A (ru) Штамм бактерий pseudomonas aeruginosa 5292, используемый для изготовления вакцины против псевдомоноза пушных зверей

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: INTERVET INTERNATIONAL B.V., NL

Free format text: FORMER OWNER(S): AKZO NOBEL N.V., NL

MM4A Lapse of definitive patent protection due to non-payment of fees